Summary & Overview
CPT 0522U: Tissue-Specific Markers for Early Diagnosis of Sjögren’s Disease
CPT code 0522U designates a Proprietary Laboratory Analyses (PLA) blood test from KSL Diagnostics Inc. that targets tissue-specific antibodies — carbonic anhydrase VI, parotid-specific protein, and salivary protein 1 (SP1) — using chemiluminescence to support early diagnosis of Sjögren’s disease. As a PLA code, 0522U applies only to this unique test and signals growing use of proprietary molecular diagnostics in autoimmune disease evaluation.
Key national payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Coverage and reimbursement approaches for PLA tests vary across payers, with implications for lab adoption and clinician ordering patterns.
Readers will find a concise overview of the clinical purpose and service setting for the test, payer inclusion in the analysis, and the types of benchmarks and policy topics typically relevant to PLA codes — including coverage policies, coding guidance, and utilization context for early Sjögren’s diagnosis. The publication does not provide state-specific guidance and focuses on national relevance for payers, laboratorians, and clinical stakeholders.
Billing Code Overview
CPT code 0522U is a Proprietary Laboratory Analyses (PLA) code for a single, manufacturer-specific blood test: Tissue Specific Markers for Early Diagnosis of Sjögren’s Disease from KSL Diagnostics Inc. The test detects antibodies to carbonic anhydrase VI, parotid–specific protein, and salivary protein 1 (SP1) using chemiluminescence to assist in the early diagnosis of Sjögren’s disease.
Service Type: Proprietary laboratory blood test for early autoimmune disease diagnosis
Typical Site of Service: Clinical laboratory or outpatient phlebotomy collection site
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 42-year-old woman presents to a rheumatology clinic with a 6-month history of dry eyes, dry mouth, intermittent parotid gland swelling, and fatigue. Initial evaluation includes focused history, ocular surface testing (Schirmer test), and serologic testing for common Sjögren’s antibodies. The clinician orders the proprietary laboratory test 0522U (Tissue Specific Markers for Early Diagnosis of Sjögren’s Disease from KSL Diagnostics Inc.) to detect antibodies to carbonic anhydrase VI, parotid-specific protein, and salivary protein 1 (SP1) using chemiluminescence.
Specimen collection is a routine peripheral blood draw performed in the outpatient laboratory or clinic (typical site of service: outpatient laboratory or physician office). The specimen is sent to the performing laboratory; 0522U is reported by the performing lab when the proprietary assay yields results. Results are reviewed by the ordering rheumatologist or primary care clinician as part of the diagnostic workup for suspected Sjögren’s disease, integrated with clinical exam, ocular testing, standard autoimmune serologies, and imaging or biopsy if indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / placeholder | Use per payer instructions when no additional modifier is required (note: not a CMS standard for reporting; included in input list as available option). |
22 | Increased procedural services | Use when documentation supports substantially greater complexity or work than typical for specimen handling or additional documentation tasks related to the test. |
26 | Professional component | Use when billing only the professional component (interpretation/report) if the performing laboratory splits technical and professional components. |
52 | Reduced services | Use when the test is partially performed or specimen inadequate but some testing was completed and billed at a reduced level. |
53 | Discontinued procedure | Use if the collection or testing was initiated but discontinued for documented clinical reasons prior to completion. |
TC | Technical component | Use when billing only the technical component (laboratory processing and analysis) by the performing lab. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RH0000X | Rheumatology | Rheumatologists commonly order 0522U when evaluating suspected Sjögren’s disease. |
| 208D00000X | Diagnostic Radiology | Radiologists may perform salivary gland imaging adjunctive to serologic testing in workup. |
| 207L00000X | Allergy & Immunology | Allergy/immunology specialists may order advanced serologic testing for autoimmune dry mouth/eyes. |
| 208000000X | Pathology | Pathologists oversee laboratory test performance, QA, and reporting in clinical laboratories. |
| 364S00000X | Laboratory Medicine | Clinical laboratory specialists and medical directors supervise and validate proprietary assays like 0522U. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
M35.0 | Sicca syndrome [Sjögren] | Primary diagnostic code for Sjögren’s disease; direct indication for ordering 0522U. |
K11.7 | Disturbances of salivary secretion, not elsewhere classified | Used when patients present with dry mouth symptoms prompting salivary-specific antibody testing. |
H04.12 | Dry eye syndrome, bilateral | Symptom-driven diagnosis often prompting evaluation for underlying autoimmune causes including Sjögren’s. |
R53.83 | Other fatigue | Nonspecific systemic symptom frequently associated with Sjögren’s and part of the clinical picture. |
M35.9 | Systemic involvement of connective tissue disease, unspecified | Used when autoimmune connective tissue disease is suspected but not yet fully classified; supports broader autoimmune testing including 0522U. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
86141 | Antinuclear antibodies (ANA) by fluorescent or equivalent technique | Common initial serologic test for autoimmune disease; often ordered concurrently to screen for autoimmunity when evaluating for Sjögren’s. |
86431 | Immunoassay for IgG, IgA, IgM antibodies; single-step method (e.g., ELISA) | Represents standard laboratory immunoassay methods used for autoantibody detection; relates as a conventional alternative or complementary testing methodology. |
87899 | Unlisted infectious disease test | Occasionally used for novel or unique laboratory tests when no specific PLA code exists; 0522U supersedes the need for an unlisted code for this proprietary assay. |
83516 | Immunoassay for tumor markers, qualitative or semiquantitative; multiple-step method | Example of an automated immunoassay CPT; included as a commonly performed laboratory immunoassay code in workflows involving serologic testing. |
82542 | Assay of salivary components (not otherwise classified) — hypothetical illustrative laboratory chemistry tests | Performed in specialized centers evaluating salivary proteins and may be part of comprehensive salivary diagnostics when assessing Sjögren’s disease. |